Duell, J., Abrisqueta, P., Andre, M., Gaidano, G., Gonzales-Barca, E., Jurczak, W., Kalakonda, N., Liberati, A. M., Maddocks, K. J., Menne, T., Nagy, Z., Tournilhac, O., Kuffer, C., Bakuli, A., Amin, A., Gurbanov, K. and Salles, G. (2023) “Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study”, Haematologica. Pavia, Italy, 109(2), pp. 553-566. doi: 10.3324/haematol.2023.283480.